The use of proteomics to identify novel therapeutic targets for the treatment of disease

Journal of Pharmacy and Pharmacology

Volumn 59, Issue 5, 2007, Pages 609-628

  Moseley, Fleur L ^a   Bicknell, Katrina A ^a   Marber, Michael S ^b   Brooks, Gavin ^a  

^a UNIVERSITY OF READING   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CELL MATURATION; DISEASE COURSE; DNA SEQUENCE; ELECTROPHORESIS; GENE EXPRESSION; GENE IDENTIFICATION; HUMAN; HUMAN GENOME PROJECT; MOLECULAR MECHANICS; PROTEIN EXPRESSION; PROTEOMICS; REVIEW;

DIAGNOSTIC TECHNIQUES AND PROCEDURES; DRUG DELIVERY SYSTEMS; DRUG DESIGN; GENE EXPRESSION REGULATION; GENOME, HUMAN; HUMANS; PROGNOSIS; PROTEOMICS;

EID: 34447298920     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1211/jpp.59.5.0001     Document Type: Review

References (145)

1. Abola, E., Kuhn, P., Earnest, T., Stevens, R. C. (2000) Automation of X-ray crystallography. Nat. Struct. Biol. 7 (Suppl.): 973-977
2. Adam, G. C., Cravatt, B. F., Sorensen, E. J. (2001) Profiling the specific reactivity of the proteome with non-directed activity-based probes. Chem. Biol. 8: 81-95
3. Adam, G. C., Sorensen, E. J., Cravatt, B. F. (2002a) Chemical strategies for functional proteomics. Mol. Cell. Proteomics 1: 781-790
4. Adam, G. C., Sorensen, E. J., Cravatt, B. F. (2002b) Trifunctional chemical probes for the consolidated detection and identification of enzyme activities from complex proteomes. Mol. Cell. Proteomics 1: 828-835
5. Alaiya, A. A., Franzen, B., Fujioka, K., Moberger, B., Schedvins, K., Silfversvard, C., Linder, S., Auer, G. (1997) Phenotypic analysis of ovarian carcinoma: polypeptide expression in benign, borderline and malignant tumors. Int. J. Cancer 73: 678-683
6. Alaiya, A. A., Roblick, U. J., Franzen, B., Bruch, H. P., Auer, G. (2003) Protein expression profiling in human lung, breast, bladder, renal, colorectal and ovarian cancers. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 787: 207-222
7. Anderson, N. G., Anderson, L. (1982) The Human Protein Index. Clin. Chem. 28: 739-748
8. Anderson, N. L., Anderson, N. G. (2002) The human plasma proteome: history, character, and diagnostic prospects. Mol. Cell. Proteomics 1: 845-867
9. Araujo, R. P., Petricoin, E. F., Liotta, L. A. (2005) A mathematical model of combination therapy using the EGFR signaling network. Biosystems 80: 57-69
10. Babuin, L., Jaffe, A. S. (2005) Troponin: the biomarker of choice for the detection of cardiac injury. CMAJ 173: 1191-1202
11. Bahk, Y. Y., Kim, S. A., Kim, J. S., Euh, H. J., Bai, G. H., Cho, S. N., Kim, Y. S. (2004) Antigens secreted from Mycobacterium tuberculosis: identification by proteomics approach and test for diagnostic marker. Proteomics 4: 3299-3307
12. Banfi, C., Brioschi, M., Wait, R., Begum, S., Gianazza, E., Fratto, P., Polvani, G., Vitali, E., Parolari, A., Mussoni, L., Tremoli, E. (2006) Proteomic analysis of membrane microdomains derived from both failing and non-failing human hearts. Proteomics 6: 1976-1988
13. Banks, R. E., Dunn, M. J., Hochstrasser, D. F., Sanchez, J. C., Blackstock, W., Pappin, D. J., Selby, P. J. (2000) Proteomics: new perspectives, new biomedical opportunities. Lancet 356: 1749-1756
14. Berger, A. B., Vitorino, P. M., Bogyo, M. (2004) Activity-based protein profiling: applications to biomarker discovery, in vivo imaging and drug discovery. Am. J. Pharmacogenomics 4: 371-381
15. Bergman, A. C., Benjamin, T., Alaiya, A., Waltham, M., Sakaguchi, K., Franzen, B., Linder, S., Bergman, T., Auer, G., Appella, E., Wirth, P. J., Jornvall, H. (2000) Identification of gel-separated tumor marker proteins by mass spectrometry. Electrophoresis 21: 679-686
16. Bertucci, F., Birnbaum, D., Goncalves, A. (2006) Proteomics of breast cancer: principles and potential clinical applications. Mol. Cell. Proteomics 5: 1772-1786
17. Blundell, T. L. (1996) Structure-based drug design. Nature 384: 23-26
18. Blundell, T. L., Jhoti, H., Abell, C. (2002) High-throughput crystallography for lead discovery in drug design. Nat. Rev. Drug Discov. 1: 45-54
19. Borozdenkova, S., Westbrook, J. A., Patel, V., Wait, R., Bolad, I., Burke, M. M., Bell, A. D., Banner, N. R., Dunn, M. J., Rose, M. L. (2004) Use of proteomics to discover novel markers of cardiac allograft rejection. J. Proteome Res. 3: 282-288
20. Boyce, E. A., Kohn, E. C. (2005) Ovarian cancer in the proteomics era: diagnosis, prognosis, and therapeutics targets. Int. J. Gynecol. Cancer 15 (Suppl. 3): 266-273
21. Brewis, I. A. (1999) Proteomics in reproductive research: the potential importance of proteomics to research in reproduction. Hum. Reprod. 14: 2927-2929
22. Brouwers, F. M., Petricoin, E. F., 3rd, Ksinantova, L., Breza, J., Rajapakse, V., Ross, S., Johann, D., Mannelli, M., Shulkin, B. L., Kvetnansky, R., Eisenhofer, G., Walther, M. M., Hitt, B. A., Conrads, T. P., Veenstra, T. D., Mannion, D. P., Wall, M. R., Wolfe, G. M., Fusaro, V. A., Liotta, L. A., Pacak, K. (2005) Low molecular weight proteomic information distinguishes metastatic from benign pheochromocytoma. Endocr. Relat. Cancer 12: 263-272
23. Burbaum, J., Tobal, G. M. (2002) Proteomics in drug discovery. Curr. Opin. Chem. Biol. 6: 427-433
24. Caputo, E., Moharram, R., Martin, B. M. (2003) Methods for onchip protein analysis. Anal. Biochem. 321: 116-124
25. Cazares, L. H., Adam, B. L., Ward, M. D., Nasim, S., Schellhammer, P. F., Semmes, O. J., Wright, G. L., Jr. (2002) Normal, benign, preneoplastic, and malignant prostate cells have distinct protein expression profiles resolved by surface enhanced laser desorption/ ionization mass spectrometry. Clin. Cancer Res. 8: 2541-2552
26. Charrier, J. P., Tournel, C., Michel, S., Comby, S., Jolivet-Reynaud, C., Passagot, J., Dalbon, P., Chautard, D., Jolivet, M. (2001) Differential diagnosis of prostate cancer and benign prostate hyperplasia using two-dimensional electrophoresis. Electrophoresis 22: 1861-1866
27. Chauhan, A., Turchan, J., Pocernich, C., Bruce-Keller, A., Roth, S., Butterfield, D. A., Major, E. O., Nath, A. (2003) Intracellular human immunodeficiency virus Tat expression in astrocytes promotes astrocyte survival but induces potent neurotoxicity at distant sites via axonal transport. J. Biol. Chem. 278: 13512-13519
28. Choi, Y. S., Pack, S. P., Yoo, Y. J. (2005) Development of a protein microarray using sequence-specific DNA binding domain on DNA chip surface. Biochem. Biophys. Res. Commun. 329: 1315-1319
29. Christendat, D., Yee, A., Dharamsi, A., Kluger, Y., Savchenko, A., Cort, J. R., Booth, V., Mackereth, C. D., Saridakis, V., Ekiel, I., Kozlov, G., Maxwell, K. L., Wu, N., McIntosh, L. P., Gehring, K., Kennedy, M. A., Davidson, A. R., Pai, E. F., Gerstein, M., Edwards, A. M., Arrowsmith, C. H. (2000) Structural proteomics of an archaeon. Nat. Struct. Biol. 7: 903-909
30. Cutler, P., Heald, G., White, I. R., Ruan, J. (2003) A novel approach to spot detection for two-dimensional gel electrophoresis images using pixel value collection. Proteomics 3: 392-401
31. Demirov, D. G., Ono, A., Orenstein, J. M., Freed, E. O. (2002) Overexpression of the N-terminal domain of TSG101 inhibits HIV-1 budding by blocking late domain function. Proc. Natl. Acad. Sci. U S A 99: 955-960
32. Dos Remedios, C. G., Liew, C. C., Allen, P. D., Winslow, R. L., Van Eyk, J. E., Dunn, M. J. (2003) Genomics, proteomics and bioinformatics of human heart failure. J. Muscle Res. Cell Motil. 24: 251-260
33. Drews, J. (2000) Drug discovery: a historical perspective. Science 287: 1960-1964
34. Edwards, A. M., Arrowsmith, C. H.; des Pallieres, B. (2000) Proteomics: New tools for a new era. Modern Drug Discovery 3: 34-46
35. Elrick, M. M., Walgren, J. L., Mitchell, M. D., Thompson, D. C. (2006) Proteomics: recent applications and new technologies. Basic Clin. Pharmacol. Toxicol. 98: 432-441
36. Engwegen, J. Y., Gast, M. C., Schellens, J. H., Beijnen, J. H. (2006) Clinical proteomics: searching for better tumour markers with SELDI-TOF mass spectrometry. Trends Pharmacol. Sci. 5: 251-259
37. Fields, S. (2005) High-throughput two-hybrid analysis. The promise and the peril. FEBS J. 272: 5391-5399
38. Franzen, B., Linder, S., Alaiya, A. A., Eriksson, E., Uruy, K., Hirano, T., Okuzawa, K., Auer, G. (1996a) Analysis of polypeptide expression in benign and malignant human breast lesions: down-regulation of cytokeratins. Br. J. Cancer 74: 1632-1638
39. Franzen, B., Auer, G., Alaiya, A. A., Eriksson, E., Uryu, K., Hirano, T., Okuzawa, K., Kato, H., Linder, S. (1996b) Assessment of homogeneity in polypeptide expression in breast carcinomas shows widely variable expression in highly malignant tumors. Int. J. Cancer 69: 408-414
40. Fu, Q., Van Eyk, J. E. (2006) Proteomics and heart disease: identifying biomarkers of clinical utility. Expert Rev. Proteomics 3: 237-249
41. Garrus, J. E., von Schwedler, U. K., Pornillos, O. W., Morham, S. G., Zavitz, K. H., Wang, H. E., Wettstein, D. A., Stray, K. M., Cote, M., Rich, R. L., Myszka, D. G., Sundquist, W. I. (2001) Tsg101 and the vacuolar protein sorting pathway are essential for HIV-1 budding. Cell 107: 55-65
42. Gharbi, S., Gaffney, P., Yang, A., Zvelebil, M. J., Cramer, R., Waterfield, M. D., Timms, J. F. (2002) Evaluation of two-dimensional differential gel electrophoresis for proteomic expression analysis of a model breast cancer cell system. Mol. Cell. Proteomics 1: 91-98
43. Goila-Gaur, R., Demirov, D. G., Orenstein, J. M., Ono, A., Freed, E. O. (2003) Defects in human immunodeficiency virus budding and endosomal sorting induced by TSG101 overexpression. J. Virol. 77: 6507-6519
44. Gorg, A., Postel, W., Gunther, S. (1988) The current state of two-dimensional electrophoresis with immobilized pH gradients. Electrophoresis 9: 531-546
45. Greer, J., Erickson, J. W., Baldwin, J. J., Varney, M. D. (1994) Application of the three-dimensional structures of protein target molecules in structure-based drug design. J. Med. Chem. 37: 1035-1054
46. Grizzle, W. E., Adam, B. L., Bigbee, W. L., Conrads, T. P., Carroll, C., Feng, Z., Izbicka, E., Jendoubi, M., Johnsey, D., Kagan, J., Leach, R. J., McCarthy, D. B., Semmes, O. J., Srivastava, S., Srivastava, S., Thompson, I. M., Thornquist, M. D., Verma, M., Zhang, Z., Zou, Z. (2003) Serum protein expression profiling for cancer detection: validation of a SELDI-based approach for prostate cancer. Dis. Markers 19: 185-195
47. Guerreiro, N., Gomez-Mancilla, B., Charmont, S. (2006) Optimization and evaluation of surface-enhanced laser-desorption/ionization time-of-flight mass spectrometry for protein profiling of cerebrospinal fluid. Proteome Sci. 4: 7
48. Gulmann, C., Sheehan, K. M., Kay, E. W., Liotta, L. A., Petricoin, E. F. (2006) Array-based proteomics: mapping of protein circuitries for diagnostics, prognostics, and therapy guidance in cancer. J. Pathol. 208: 595-606
49. Gygi, S. P., Rist, B., Gerber, S. A., Turecek, F., Gelb, M. H., Aebersold, R. (1999) Quantitative analysis of complex protein mixtures using isotope-coded affinity tags. Nat. Biotechnol. 17: 994-999
50. Gygi, S. P., Corthals, G. L., Zhang, Y., Rochon, Y., Aebersold, R. (2000) Evaluation of two-dimensional gel electrophoresis-based proteome analysis technology. Proc. Natl. Acad. Sci. U S A 97: 9390-9395
51. Gygi, S. P., Rist, B., Griffin, T. J., Eng, J., Aebersold, R. (2002) Proteome analysis of low-abundance proteins using multidimensional chromatography and isotope-coded affinity tags. J. Proteome Res. 1: 47-54
52. Haab, B. B. (2003) Methods and applications of antibody microarrays in cancer research. Proteomics 3: 2116-2122
53. Hagenstein, M. C., Sewald, N. (2006) Chemical tools for activity-based proteomics. J. Biotechnol. 124: 56-73
54. Harper, R. G., Workman, S. R., Schuetzner, S., Timperman, A. T., Sutton, J. N. (2004) Low-molecular-weight human serum proteome using ultrafiltration, isoelectric focusing, and mass spectrometry. Electrophoresis 25: 1299-1306
55. Harry, J. L., Wilkins, M. R., Herbert, B. R., Packer, N. H., Gooley, A. A., Williams, K. L. (2000) Proteomics: capacity versus utility. Electrophoresis 21: 1071-1081
56. Hudelist, G., Singer, C. F., Pischinger, K. I., Kaserer, K., Manavi, M., Kubista, E., Czerwenka, K. F. (2006) Proteomic analysis in human breast cancer: identification of a characteristic protein expression profile of malignant breast epithelium. Proteomics 6: 1989-2002
57. International Human Genome Sequencing Consortium (2004) Finishing the euchromatic sequence of the human genome. Nature 431: 931-945
58. Ito, T., Chiba, T., Ozawa, R., Yoshida, M., Hattori, M., Sakaki, Y. (2001) A comprehensive two-hybrid analysis to explore the yeast protein interactome. Proc. Natl. Acad. Sci. U S A 98: 4569-4574
59. Janssen, R. S., Nwanyanwu, O. C., Selik, R. M., Stehr-Green, J. K. (1992) Epidemiology of human immunodeficiency virus encephalopathy in the United States. Neurology 42: 1472-1476
60. Jarai, R., Wojta, J., Huber, K. (2005) Circulating B-type natriuretic peptides in patients with acute coronary syndromes. Pathophysiological, prognostical and therapeutical considerations. Thromb. Haemost. 94: 926-932
61. Jung, J. W., Lee, W. (2004) Structure-based functional discovery of proteins: structural proteomics. J. Biochem. Mol. Biol. 37: 28-34
62. Jungblut, P. R., Zimny-Arndt, U., Zeindl-Eberhart, E., Stulik, J., Koupilova, K., Pleissner, K. P., Otto, A., Muller, E. C., Sokolowska-Kohler, W., Grabher, G., Stoffler, G. (1999) Proteomics in human disease: cancer, heart and infectious diseases. Electrophoresis 20: 2100-2110
63. Kavallaris, M., Marshall, G. M. (2005) Proteomics and disease: opportunities and challenges. Med. J. Aust. 182: 575-579
64. Kingsmore, S. F. (2006) Multiplexed protein measurement: technologies and applications of protein and antibody arrays. Nat. Rev. Drug Discov. 5: 310-320
65. Kononen, J., Bubendorf, L., Kallioniemi, A., Barlund, M., Schraml, P., Leighton, S., Torhorst, J., Mihatsch, M. J., Sauter, G., Kallioniemi, O. P. (1998) Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat. Med. 4: 844-847
66. Kovarova, H., Hajduch, M., Korinkova, G., Halada, P., Krupickova, S., Gouldsworthy, A., Zhelev, N., Strnad, M. (2000) Proteomics approach in classifying the biochemical basis of the anticancer activity of the new olomoucine-derived synthetic cyclin-dependent kinase inhibitor, bohemine. Electrophoresis 21: 3757-3764
67. Kozak, K. R., Amneus, M. W., Pusey, S. M., Su, F., Luong, M. N., Luong, S. A., Reddy, S. T., Farias-Eisner, R. (2003) Identification of biomarkers for ovarian cancer using strong anion-exchange ProteinChips: potential use in diagnosis and prognosis. Proc. Natl. Acad. Sci. USA 100: 12343-12348
68. Link, A. J., Eng, J., Schieltz, D. M., Carmack, E., Mize, G. J., Morris, D. R., Garvik, B. M., Yates, J. R. (1999) Direct analysis of protein complexes using mass spectrometry. Nat. Biotechnol. 17: 676-682
69. Liu, H., Lin, D., Yates, J. R. (2002) Multidimensional separations for protein/peptide analysis in the post-genomic era. Biotechniques 32: 898, 900, 902 passim
70. Liu, H. L., Hsu, J. P. (2005) Recent developments in structural proteomics for protein structure determination. Proteomics 5: 2056-2068
71. Lockhart, D. J., Winzeler, E. A. (2000) Genomics, gene expression and DNA arrays. Nature 405: 827-836
72. Louhimo, J., Finne, P., Alfthan, H., Stenman, U. H., Haglund, C. (2002) Combination of HCGbeta, CA 19-9 and CEA with logistic regression improves accuracy in gastrointestinal malignancies. Anticancer Res. 22: 1759-1764
73. MacBeath, G., Schreiber, S. L. (2000) Printing proteins as microarrays for high-throughput function determination. Science 289: 1760-1763
74. Mackintosh, J. A., Choi, H. Y., Bae, S. H., Veal, D. A., Bell, P. J., Ferrari, B. C., Van Dyk, D. D., Verrills, N. M., Paik, Y. K., Karuso, P. (2003) A fluorescent natural product for ultra sensitive detection of proteins in one-dimensional and two-dimensional gel electrophoresis. Proteomics 3: 2273-2288
75. Maggio, E. T., Ramnarayan, K. (2001) Recent developments in computational proteomics. Trends Biotechnol. 19: 266-272
76. Mahon, P., Dupree, P. (2001) Quantitative and reproducible two-dimensional gel analysis using Phoretix 2D Full. Electrophoresis 22: 2075-2085
77. Malik, A. N., Godfrey-Faussett, P. (2005) Effects of genetic variability of Mycobacterium tuberculosis strains on the presentation of disease. Lancet Infect. Dis. 5: 174-183
78. Mann, M., Hendrickson, R. C., Pandey, A. (2001) Analysis of proteins and proteomes by mass spectrometry. Annu. Rev. Biochem. 70: 437-473
79. Marouga, R., David, S., Hawkins, E. (2005) The development of the DIGE system: 2D fluorescence difference gel analysis technology. Anal. Bioanal. Chem. 382: 669-678
80. Marshall, T., Williams, K. M. (2002) Proteomics and its impact upon biomedical science. Br. J. Biomed. Sci. 59: 47-64
81. Martin-Serrano, J., Zang, T., Bieniasz, P. D. (2001) HIV-1 and Ebola virus encode small peptide motifs that recruit Tsg101 to sites of particle assembly to facilitate egress. Nat. Med. 7: 1313-1319
82. Mayr, M., Zhang, J., Greene, A. S., Gutterman, D. D., Perloff, J. K., Ping, P. (2006) Proteomic based development of biomarkers in cardiovascular disease: Mechanistic, clinical, and therapeutic insights. Mol. Cell. Proteomics 5: 1853-1864
83. McDonough, J. L., Van Eyk, J. E. (2004) Developing the next generation of cardiac markers: disease-induced modifications of troponin I. Prog. Cardiovasc. Dis. 47: 207-216
84. McGregor, E., Dunn, M. J. (2006) Proteomics of the heart: unraveling disease. Circ. Res. 98: 309-321
85. Menard, C., Johann, D., Lowenthal, M., Muanza, T., Sproull, M., Ross, S., Gulley, J., Petricoin, E., Coleman, C. N., Whiteley, G., Liotta, L., Camphausen, K. (2006) Discovering clinical biomarkers of ionizing radiation exposure with serum proteomic analysis. Cancer Res. 66: 1844-1850
86. Michnick, S. W., Remy, I., Campbell-Valois, F. X., Vallee-Belisle, A., Pelletier, J. N. (2000) Detection of protein-protein interactions by protein fragment complementation strategies. Methods Enzymol. 328: 208-230
87. Moritz, R. L., Ji, H., Schutz, F., Connolly, L. M., Kapp, E. A., Speed, T. P., Simpson, R. J. (2004) A proteome strategy for fractionating proteins and peptides using continuous free-flow electrophoresis coupled off-line to reversed-phase high-performance liquid chromatography. Anal. Chem. 76: 4811-4824
88. Nielsen, U. B., Geierstanger, B. H. (2004) Multiplexed sandwich assays in microarray format. J. Immunol. Methods 290: 107-120
89. O'Brien, S. E., Brown, D. G., Mills, J. E., Phillips, C., Morris, G. (2005) Computational tools for the analysis and visualization of multiple protein-ligand complexes. J. Mol. Graph. Model 24: 186-194
90. Ogasawara, K., Mashiba, S., Wada, Y., Sahara, M., Uchida, K., Aizawa, T., Kodama, T. (2004) A serum amyloid A and LDL complex as a new prognostic marker in stable coronary artery disease. Atherosclerosis 174: 349-356
91. Ornstein, D. K., Tyson, D. R. (2006) Proteomics for the identification of new prostate cancer biomarkers. Urol. Oncol. 24: 231-236
92. Ostergaard, M., Rasmussen, H. H., Nielsen, H. V., Vorum, H., Orntoft, T. F., Wolf, H., Celis, J. E. (1997) Proteome profiling of bladder squamous cell carcinomas: identification of markers that define their degree of differentiation. Cancer Res. 57: 4111-4117
93. Pandey, A., Mann, M. (2000) Proteomics to study genes and genomes. Nature 405: 837-846
94. Paweletz, C. P., Charboneau, L., Bichsel, V. E., Simone, N. L., Chen, T., Gillespie, J. W., Emmert-Buck, M. R., Roth, M. J., Petricoin, I. E., Liotta, L. A. (2001) Reverse phase protein microarrays which capture disease progression show activation of prosurvival pathways at the cancer invasion front. Oncogene 20: 1981-1989
95. Pervushin, K., Riek, R., Wider, G., Wuthrich, K. (1997) Attenuated T2 relaxation by mutual cancellation of dipole-dipole coupling and chemical shift anisotropy indicates an avenue to NMR structures of very large biological macromolecules in solution. Proc. Natl. Acad. Sci. USA 94: 12366-12371
96. Petricoin, E. F., Liotta, L. A. (2004) SELDI-TOF-based serum proteomic pattern diagnostics for early detection of cancer. Curr. Opin. Biotechnol. 15: 24-30
97. Phizicky, E. M., Fields, S. (1995) Protein-protein interactions: methods for detection and analysis. Microbiol. Rev. 59: 94-123
98. Pixton, K. L. (2004) Is it functional? Report on the first BSPR/EBI meeting on functional proteomics. Proteomics 4: 3762-3764
99. Pocernich, C. B., Boyd-Kimball, D., Poon, H. F., Thongboonkerd, V., Lynn, B. C., Klein, J. B., Calebrese, V., Nath, A., Butterfield, D. A. (2005) Proteomics analysis of human astrocytes expressing the HIV protein Tat. Brain Res. Mol. Brain Res. 133: 307-316
100. Qu, Y., Adam, B. L., Yasui, Y., Ward, M. D., Cazares, L. H., Schellhammer, P. F., Feng, Z., Semmes, O. J., Wright, G. L. (2002) Boosted decision tree analysis of surface-enhanced laser desorption/ ionization mass spectral serum profiles discriminates prostate cancer from noncancer patients. Clin. Chem. 48: 1835-1843
101. Rajappa, M., Sharma, A. (2005) Biomarkers of cardiac injury: an update. Angiology 56: 677-691
102. Ramachandran, N., Larson, D. N., Stark, P. R., Hainsworth, E., LaBaer, J. (2005) Emerging tools for real-time label-free detection of interactions on functional protein microarrays. FEBS J. 272: 5412-5425
103. Ren, Y., He, Q. Y., Fan, J., Jones, B., Zhou, Y., Xie, Y., Cheung, C. Y., Wu, A., Chiu, J. F., Peiris, J. S., Tam, P. K. (2004) The use of proteomics in the discovery of serum biomarkers from patients with severe acute respiratory syndrome. Proteomics 4: 3477-3484
104. Ridker, P. M., Stampfer, M. J., Rifai, N. (2001) Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease. JAMA 285: 2481-2485
105. Ross, P. L., Huang, Y. N., Marchese, J. N., Williamson, B., Parker, K., Hattan, S., Khainovski, N., Pillai, S., Dey, S., Daniels, S., Purkayastha, S., Juhasz, P., Martin, S., Bartlet-Jones, M., He, F., Jacobson, A., Pappin, D. J. (2004) Multiplexed protein quantitation in Saccharomyces cerevisiae using amine-reactive isobaric tagging reagents. Mol. Cell. Proteomics 3: 1154-1169
106. Santoni, V., Molloy, M., Rabilloud, T. (2000) Membrane proteins and proteomics: un amour impossible? Electrophoresis 21: 1054-1070
107. Sarioglu, H., Brandner, S., Jacobsen, C., Meindl, T., Schmidt, A., Kellermann, J., Lottspeich, F., Andrae, U. (2006) Quantitative analysis of 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced proteome alterations in 5L rat hepatoma cells using isotope-coded protein labels. Proteomics 6: 2407-2421
108. Schaub, S., Rush, D., Wilkins, J., Gibson, I. W., Weiler, T., Sangster, K., Nicolle, L., Karpinski, M., Jeffery, J., Nickerson, P. (2004) Proteomic-based detection of urine proteins associated with acute renal allograft rejection. J. Am. Soc. Nephrol. 15: 219-227
109. Schena, M., Heller, R. A., Theriault, T. P., Konrad, K., Lachenmeier, E., Davis, R. W. (1998) Microarrays: biotechnology's discovery platform for functional genomics. Trends Biotechnol. 16: 301-306
110. Schmidt, A., Kellermann, J., Lottspeich, F. (2005) A novel strategy for quantitative proteomics using isotope-coded protein labels. Proteomics 5: 4-15
111. Semmes, O. J., Feng, Z., Adam, B. L., Banez, L. L., Bigbee, W. L., Campos, D., Cazares, L. H., Chan, D. W., Grizzle, W. E., Izbicka, E., Kagan, J., Malik, G., McLerran, D., Moul, J. W., Partin, A., Prasanna, P., Rosenzweig, J., Sokoll, L. J., Srivastava, S., Srivastava, S., Thompson, I., Welsh, M. J., White, N., Winget, M., Yasui, Y., Zhang, Z., Zhu, L. (2005) Evaluation of serum protein profiling by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry for the detection of prostate cancer: I. Assessment of platform reproducibility. Clin. Chem. 51: 102-112
112. Semmes, O. J., Malik, G., Ward, M. (2006) Application of mass spectrometry to the discovery of biomarkers for detection of prostate cancer. J. Cell Biochem. 98: 496-503
113. Service, R. F. (1998) NMR researchers look to the next generation of machines. Science 279: 1127-1128
114. Skalnikova, H., Halada, P., Dzubak, P., Hajduch, M., Kovarova, H. (2005) Protein fingerprints of anti-cancer effects of cyclin-dependent kinase inhibition: identification of candidate biomarkers using 2-D liquid phase separation coupled to mass spectrometry. Technol. Cancer Res. Treat. 4: 447-454
115. Smolka, M., Zhou, H., Aebersold, R. (2002) Quantitative protein profiling using two-dimensional gel electrophoresis, isotope-coded affinity tag labeling, and mass spectrometry. Mol. Cell. Proteomics 1: 19-29
116. Souchelnytskyi, S. (2005) Bridging proteomics and systems biology: what are the roads to be traveled? Proteomics 5: 4123-4137
117. Stagljar, I., Korostensky, C., Johnsson, N., te Heesen, S. (1998) A genetic system based on split-ubiquitin for the analysis of interactions between membrane proteins in vivo. Proc. Natl. Acad. Sci. U S A 95: 5187-5192
118. Stulik, J., Kovarova, H., Macela, A., Bures, J., Jandik, P., Langr, F., Otto, A., Thiede, B., Jungblut, P. (1997) Overexpression of calcium-binding protein calgranulin B in colonic mucosal diseases. Clin. Chim. Acta 265: 41-55
119. Tang, H., Peng, T., Wong-Staal, F. (2002) Novel technologies for studying virus-host interaction and discovering new drug targets for HCV and HIV. Curr. Opin. Pharmacol. 2: 541-547
120. Tari, L. W., Rosenberg, M., Schryvers, A. B. (2005) Structural proteomics in drug discovery. Expert Rev. Proteomics 2: 511-519
121. Tchabo, N. E., Liel, M. S., Kohn, E. C. (2005) Applying proteomics in clinical trials: assessing the potential and practical limitations in ovarian cancer. Am. J. Pharmacogenomics 5: 141-148
122. Tirumalai, R. S., Chan, K. C., Prieto, D. A., Issaq, H. J., Conrads, T. P., Veenstra, T. D. (2003) Characterization of the low molecular weight human serum proteome. Mol Cell Proteomics 2: 1096-1103
123. Tyers, M., Mann, M. (2003) From genomics to proteomics. Nature 422: 193-197
124. Unlu, M., Morgan, M. E., Minden, J. S. (1997) Difference gel electrophoresis: a single gel method for detecting changes in protein extracts. Electrophoresis 18: 2071-2077
125. Valway, S. E., Sanchez, M. P., Shinnick, T. F., Orme, I., Agerton, T., Hoy, D., Jones, J. S., Westmoreland, H., Onorato, I. M. (1998) An outbreak involving extensive transmission of a virulent strain of Mycobacterium tuberculosis. N. Engl. J. Med. 338: 633-639
126. VerPlank, L., Bouamr, F., LaGrassa, T. J., Agresta, B., Kikonyogo, A., Leis, J., Carter, C. A. (2001) Tsg101, a homologue of ubiquitin-conjugating (E2) enzymes, binds the L domain in HIV type 1 Pr55(Gag). Proc. Natl. Acad. Sci. U S A 98: 7724-7729
127. Verrills, N. M., Walsh, B. J., Cobon, G. S., Hains, P. G., Kavallaris, M. (2003) Proteome analysis of vinca alkaloid response and resistance in acute lymphoblastic leukemia reveals novel cytoskeletal alterations. J. Biol. Chem. 278: 45082-45093
128. Villanueva, J., Philip, J., Entenberg, D., Chaparro, C. A., Tanwar, M. K., Holland, E. C., Tempst, P. (2004) Serum peptide profiling by magnetic particle-assisted, automated sample processing and MALDI-TOF mass spectrometry. Anal. Chem. 76: 1560-1570
129. Vishnevetsky, D., Kiyanista, V. A., Gandhi, P. J. (2004) CD40 ligand: a novel target in the fight against cardiovascular disease. Ann. Pharmacother. 38: 1500-1508
130. Vivanco, F., Martin-Ventura, J. L., Duran, M. C., Barderas, M. G., Blanco-Colio, L., Darde, V. M., Mas, S., Meilhac, O., Michel, J. B., Tunon, J., Egido, J. (2005) Quest for novel cardiovascular biomarkers by proteomic analysis. J. Proteome Res. 4: 1181-1191
131. Wang, M. Z., Howard, B., Campa, M. J., Patz, E. F., Fitzgerald, M. C. (2003) Analysis of human serum proteins by liquid phase isoelectric focusing and matrix-assisted laser desorption/ionization-mass spectrometry. Proteomics 3: 1661-1666
132. Washburn, M. P., Wolters, D., Yates, J. R. (2001) Large-scale analysis of the yeast proteome by multidimensional protein identification technology. Nat. Biotechnol. 19: 242-247
133. Wasinger, V. C., Cordwell, S. J., Cerpa-Poljak, A., Yan, J. X., Gooley, A. A., Wilkins, M. R., Duncan, M. W., Harris, R., Williams, K. L., Humphery-Smith, I. (1995) Progress with gene-product mapping of the Mollicutes: Mycoplasma genitalium. Electrophoresis 16: 1090-1094
134. Wehrman, T., Kleaveland, B., Her, J. H., Balint, R. F., Blau, H. M. (2002) Protein-protein interactions monitored in mammalian cells via complementation of beta-lactamase enzyme fragments. Proc. Natl. Acad. Sci. U S A 99: 3469-3474
135. Westbrook, J. A., Wheeler, J. X., Wait, R., Welson, S. Y., Dunn, M. J. (2006) The human heart proteome: Two-dimensional maps using narrow-range immobilised pH gradients. Electrophoresis 27: 1547-1555
136. White, I. R., Pickford, R., Wood, J., Skehel, J. M., Gangadharan, B., Cutler, P. (2004) A statistical comparison of silver and SYPRO Ruby staining for proteomic analysis. Electrophoresis 25: 3048-3054
137. Wilkins, M. R., Sanchez, J. C., Gooley, A. A., Appel, R. D., Humphery-Smith, I., Hochstrasser, D. F., Williams, K. L. (1996a) Progress with proteome projects: why all proteins expressed by a genome should be identified and how to do it. Biotechnol. Genet. Eng. Rev. 13: 19-50
138. Wilkins, M. R., Pasquali, C., Appel, R. D., Ou, K., Golaz, O., Sanchez, J. C., Yan, J. X., Gooley, A. A., Hughes, G., Humphery-Smith, I., Williams, K. L., Hochstrasser, D. F. (1996b) From proteins to proteomes: large scale protein identification by two-dimensional electrophoresis and amino acid analysis. Biotechnology (N Y) 14: 61-65
139. Wolters, D. A., Washburn, M. P., Yates, J. R. (2001) An automated multidimensional protein identification technology for shotgun proteomics. Anal. Chem. 73: 5683-5690
140. Wu, A. H. (2005) Markers for early detection of cardiac diseases. Scand. J. Clin. Lab. Invest. Suppl. 240: 112-121
141. Wu, W. W., Wang, G., Baek, S. J., Shen, R. F. (2006) Comparative study of three proteomic quantitative methods, DIGE, cICAT, and iTRAQ, using 2D gel- or LC-MALDI TOF/TOF. J. Proteome Res. 5: 651-658
142. Xiao, Z., Adam, B. L., Cazares, L. H., Clements, M. A., Davis, J. W., Schellhammer, P. F., Dalmasso, E. A., Wright, G. L., Jr. (2001) Quantitation of serum prostate-specific membrane antigen by a novel protein biochip immunoassay discriminates benign from malignant prostate disease. Cancer Res. 61: 6029-6033
143. Xiao, Z., Conrads, T. P., Lucas, D. A., Janini, G. M., Schaefer, C. F., Buetow, K. H., Issaq, H. J., Veenstra, T. D. (2004) Direct ampholyte-free liquid-phase isoelectric peptide focusing: application to the human serum proteome. Electrophoresis 25: 128-133
144. Zhu, H., Snyder, M. (2003) Protein chip technology. Curr. Opin. Chem. Biol. 7: 55-63
145. Zimmerman, C., Klein, K. C., Kiser, P. K., Singh, A. R., Firestein, B. L., Riba, S. C., Lingappa, J. R. (2002) Identification of a host protein essential for assembly of immature HIV-1 capsids. Nature 415: 88-92